Gilead Sciences, Inc. (GILD)
Healthcare • Drug Manufacturers - General
StockNasdaqGSUnited StatesUS3755581036
167.97 USD
+0.01% today Updated 13 Nov 2026 15:28
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Gilead Sciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
09 Feb 2027
in 88 days · 16:00 · estimate 1.09
Last results
2.55 vs 2.19 estimated
29 Oct 2026 · Beat +16.2%
Beat the estimate
11 of 12
1 missed · 0 in line · 11 beats in a row
Average surprise
+10.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Feb 2027 16:00 | 1.09 | — | — | Upcoming |
| 29 Oct 2026 16:00 | 2.19 | 2.55 | +16.2% | Beat |
| 04 Aug 2026 16:00 | -7.25 | -6.75 | +6.9% | Beat |
| 07 May 2026 16:00 | 1.91 | 2.03 | +6.2% | Beat |
| 10 Feb 2026 16:00 | 1.81 | 1.86 | +2.8% | Beat |
| 30 Oct 2025 16:00 | 2.14 | 2.47 | +15.7% | Beat |
| 07 Aug 2025 16:00 | 1.96 | 2.01 | +2.7% | Beat |
| 24 Apr 2025 16:00 | 1.78 | 1.81 | +1.9% | Beat |
| 11 Feb 2025 16:00 | 1.70 | 1.90 | +11.7% | Beat |
| 06 Nov 2024 16:00 | 1.55 | 2.02 | +30.5% | Beat |
| 08 Aug 2024 16:00 | 1.60 | 2.01 | +25.7% | Beat |
| 25 Apr 2024 16:00 | -1.52 | -1.32 | +13.1% | Beat |
| 06 Feb 2024 16:00 | 1.76 | 1.72 | -2.3% | Miss |
| 07 Nov 2023 16:00 | 1.92 | 2.29 | +19.6% | Beat |
| 03 Aug 2023 16:00 | 1.64 | 1.34 | -18.3% | Miss |
| 27 Apr 2023 16:00 | 1.54 | 1.37 | -10.8% | Miss |
| 02 Feb 2023 16:00 | 1.51 | 1.67 | +10.9% | Beat |
| 27 Oct 2022 16:00 | 1.43 | 1.90 | +32.9% | Beat |
| 02 Aug 2022 16:00 | 1.52 | 1.58 | +3.9% | Beat |
| 28 Apr 2022 16:00 | 1.81 | 2.12 | +17.2% | Beat |
| 01 Feb 2022 16:00 | 1.59 | 0.69 | -56.6% | Miss |
| 28 Oct 2021 16:00 | 1.78 | 2.65 | +48.7% | Beat |
| 29 Jul 2021 16:00 | 1.75 | 1.87 | +7.1% | Beat |
| 29 Apr 2021 16:00 | 2.11 | 2.08 | -1.5% | Miss |
| 04 Feb 2021 16:00 | 2.15 | 2.19 | +2.0% | Beat |
| 28 Oct 2020 16:00 | 1.89 | 2.11 | +11.9% | Beat |
| 30 Jul 2020 16:00 | 1.45 | 1.11 | -23.4% | Miss |
| 30 Apr 2020 17:00 | 1.56 | 1.68 | +7.5% | Beat |
| 04 Feb 2020 16:00 | 1.67 | 1.30 | -22.3% | Miss |
| 24 Oct 2019 16:00 | 1.73 | 1.75 | +1.0% | In line |
| 30 Jul 2019 16:00 | 1.71 | 1.82 | +6.4% | Beat |
| 02 May 2019 16:00 | 1.60 | 1.76 | +9.8% | Beat |
| 04 Feb 2019 16:00 | 1.69 | 1.44 | -15.0% | Miss |
| 25 Oct 2018 16:00 | 1.63 | 1.84 | +13.1% | Beat |
| 25 Jul 2018 16:00 | 1.56 | 1.91 | +22.2% | Beat |
| 01 May 2018 16:00 | 1.67 | 1.48 | -11.3% | Miss |
| 06 Feb 2018 16:00 | 1.67 | 1.78 | +6.3% | Beat |
| 26 Oct 2017 16:00 | 2.13 | 2.27 | +6.6% | Beat |
| 26 Jul 2017 16:00 | 2.17 | 2.56 | +17.7% | Beat |
| 02 May 2017 16:00 | 2.28 | 2.23 | -2.3% | Miss |
| 07 Feb 2017 16:00 | 2.60 | 2.70 | +3.8% | Beat |
| 01 Nov 2016 16:00 | 2.83 | 2.75 | -3.0% | Miss |
| 25 Jul 2016 16:00 | 3.01 | 3.08 | +2.2% | Beat |
| 28 Apr 2016 16:00 | 3.13 | 3.03 | -3.3% | Miss |
| 02 Feb 2016 16:00 | 2.97 | 3.32 | +11.8% | Beat |
| 27 Oct 2015 16:00 | 2.87 | 3.22 | +12.3% | Beat |
| 28 Jul 2015 16:00 | 2.71 | 3.15 | +16.2% | Beat |
| 30 Apr 2015 16:00 | 2.29 | 2.94 | +28.3% | Beat |
| 03 Feb 2015 16:00 | 2.18 | 2.43 | +11.4% | Beat |
| 28 Oct 2014 16:00 | 1.90 | 1.84 | -3.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 29.4B | +2.4% | 8.5B | 28.9% | 6.78 | +1,684.2% | 9.5B |
| 2024 | 28.8B | +6.0% | 480M | 1.7% | 0.38 | -91.6% | 10.3B |
| 2023 | 27.1B | -0.6% | 5.7B | 20.9% | 4.50 | +23.6% | 7.4B |
| 2022 | 27.3B | — | 4.6B | 16.8% | 3.64 | — | 8.3B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 169.21 | 171.70 | 165.99 | 167.97 | +0.65% | 18,810,376 | |
| 02 Nov 2026 – 06 Nov 2026 | 169.85 | 176.58 | 164.00 | 166.89 | -2.22% | 42,288,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 157.62 | 175.65 | 155.76 | 170.68 | +9.38% | 35,840,400 | |
| 19 Oct 2026 – 23 Oct 2026 | 155.39 | 157.65 | 151.71 | 156.04 | -0.10% | 31,128,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 151.84 | 160.51 | 147.26 | 156.19 | +3.32% | 33,164,400 | |
| 05 Oct 2026 – 09 Oct 2026 | 143.21 | 151.44 | 142.60 | 151.17 | +4.44% | 25,249,200 | |
| 28 Sep 2026 – 02 Oct 2026 | 149.80 | 152.74 | 144.00 | 144.74 | -4.10% | 25,238,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 150.11 | 154.20 | 148.02 | 150.93 | +0.55% | 27,199,900 | |
| 14 Sep 2026 – 18 Sep 2026 | 144.26 | 153.23 | 142.94 | 150.11 | +4.45% | 38,894,700 | 0.8200 |
| 08 Sep 2026 – 11 Sep 2026 | 146.98 | 148.65 | 143.50 | 143.72 | -4.82% | 20,884,300 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ... (opens in a new tab) GuruFocus.com · 12 Nov 2026 23:03
- Top Research Reports for Home Depot, Gilead & TotalEnergies (opens in a new tab) Zacks · 12 Nov 2026 20:07
- Can Gilead Sciences' HIV Business Fuel Sustainable Long-Term Growth? (opens in a new tab) Zacks · 12 Nov 2026 16:20
- Gilead Brings HIV Prevention to the 27th Annual Latin GRAMMY Awards® (opens in a new tab) 12 Nov 2026 13:30
- Gilead (GILD) Stock Still Looks Undervalued On Its 205% Run (opens in a new tab) Simply Wall St. · 11 Nov 2026 15:10
- Advanced Therapy Medicinal Products - Global Strategic Business Report: Capitalize on 11.8% CAGR to Secure $25.4B by 2030 as Novartis, Gilead, Bristol-Myers Squibb and Roche Compete (opens in a new tab) 11 Nov 2026 14:27
- Gilead Sciences (GILD) Posts PURPOSE 5 Win As HIV Shot Beats Daily Pills (opens in a new tab) Simply Wall St. · 11 Nov 2026 14:12
- Gilead Sciences (GILD) After Trial Wins And Raised Guidance Looks Fully Valued (opens in a new tab) Simply Wall St. · 11 Nov 2026 13:11
- iShares Biotechnology ETF (IBB) Adds Gilead and Amgen on Nov. 9 (opens in a new tab) GuruFocus.com · 11 Nov 2026 11:04
- EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat (opens in a new tab) Benzinga · 11 Nov 2026 10:56
- Can Gilead’s Cash Keep Growing? (opens in a new tab) Trefis · 10 Nov 2026 20:18
- Gilead Sciences Targets 200 Treatment Centers for Potential Anito-Cel Launch (opens in a new tab) MarketBeat · 10 Nov 2026 18:15
- Merck vs. Gilead Sciences: Which Dividend Stock Pays You More in 10 Years? (opens in a new tab) TIKR · 10 Nov 2026 17:57
- Gilead Sciences, Inc. (GILD) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 14:11
- Gilead Sciences Stock Hits a New All-Time High: Is it Still a Good Buy? (opens in a new tab) Motley Fool · 10 Nov 2026 11:09
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 167.95 USD
- Market cap
- 210.0B
- Dividend yield
- 1.94%
- 5-year average yield
- 3.28%
- Payout ratio
- 43%
- Last dividend
- 0.8200 USD · 15 Dec 2026
- Next ex-dividend date
- 15 Dec 2026
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 15 Sep 2026 | 0.8200 USD |
| 15 Jun 2026 | 0.8200 USD |
| 13 Mar 2026 | 0.8200 USD |
| 15 Dec 2025 | 0.7900 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow GILD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.